Viral hepatitis
MONDO:0006011An acute or chronic inflammation of the liver parenchyma caused by viruses. Representative examples include hepatitis A, B, and C, cytomegalovirus hepatitis, and herpes simplex hepatitis.
Also known as: Hepatitis viral, Viruses caused hepatitis, Viruses hepatitis, viral Hepatitis, viral human hepatitis, unspecified viral hepatitis with hepatic coma, viral hepatitis with hepatic coma
446 clinical trials for this condition and its sub-types, 12 tagged with Viral hepatitis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Part of
Sub-types of Viral hepatitis
-
Hepatitis B virus infection 251 trials · 274 incl. sub-types
2 sub-types
- Chronic hepatitis B virus infection 171 trials
- Acute hepatitis B virus infection 2 trials
-
Hepatitis C virus infection 158 trials · 162 incl. sub-types
2 sub-types
- Chronic hepatitis C virus infection 43 trials
- Acute hepatitis C virus infection 0 trials
-
Hepatitis D virus infection 47 trials
-
Hepatitis A virus infection 10 trials
-
Hepatitis E virus infection 5 trials
-
Epstein-Barr virus hepatitis 0 trials
-
New drug combo aims to tackle stubborn hepatitis d
Disease control OngoingThis Phase 3 trial tests whether a combination of two drugs, tobevibart and elebsiran, can suppress hepatitis D virus in adults who are still infected despite taking bulevirtide. About 150 participants will receive the combo as injections. The main goal is to see if the virus bec…
Phase 3 • Sponsor: Vir Biotechnology, Inc. • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New drug duo aims to control hard-to-treat hepatitis delta
Disease control OngoingThis phase 3 study tests whether a combination of two drugs, tobevibart and elebsiran, can control chronic hepatitis delta better than waiting for treatment. About 124 adults with the infection will receive either the combo therapy or delayed treatment. The goal is to see if the …
Phase 3 • Sponsor: Vir Biotechnology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New drug duo takes on rare liver virus in head-to-head trial
Disease control OngoingThis study tests whether a combination of two experimental drugs (Tobevibart and Elebsiran) works better than the current treatment Bulevirtide for people with chronic hepatitis D, a serious liver infection. About 100 adults with stable liver disease will receive either the combo…
Phase 2 • Sponsor: Vir Biotechnology, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC